chymotrypsin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   4 Trials   4 Trials   679 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
chymotrypsin / Generic mfg.
NCT02649959: An Open Label Study of CM-AT for the Treatment of Children With Autism

Active, not recruiting
3
405
US
CM-AT
Curemark
Autism
01/25
01/25
NCT06722664: Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.

Recruiting
2
336
RoW
Recombinant Human Chymotrypsin(OsrhCT) 4000U, Placebo for Recombinant Human Chymotrypsin(OsrhCT), Dimethicone emulsion 4ml
Healthgen Biotechnology Corp., Beijing Friendship Hospital
Gastric Mucosal Lesion
04/25
06/25
NCT06525272: A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy

Not yet recruiting
1
72
RoW
Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Recombinant Human Chymotrypsin(OsrhCT), Placebo for Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Placebo for Recombinant Human Chymotrypsin(OsrhCT)
Healthgen Biotechnology Corp.
Pleurisy
07/25
12/25
ChiCTR2200059070: Clinical study of antivenom blockade in the treatment of local tissue necrosis caused by Chinese cobra (Naja atra) bites

Recruiting
N/A
50
 
Regular treatment plus chymotrypsin blocking therapy ;Regular treatment and antivenom serum blocking treatment
Shenzhen Traditional Chinese Medicine Hospital; Shenzhen Traditional Chinese Medicine Hospital, Guangdong Medical Research Foundation
Snakebite
 
 

Download Options